BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Consalvi S, Poce G, Ghelardini C, Di Cesare Mannelli L, Patrignani P, Bruno A, Anzini M, Calderone V, Martelli A, Testai L, Giordani A, Biava M. Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis. Eur J Med Chem 2021;210:112983. [PMID: 33168231 DOI: 10.1016/j.ejmech.2020.112983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Alonso-gonzález M, Fernández-carballido A, Quispe-chauca P, Lozza I, Martín-sabroso C, Isabel Fraguas-sánchez A. DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect. European Journal of Pharmaceutics and Biopharmaceutics 2022;180:149-160. [DOI: 10.1016/j.ejpb.2022.09.022] [Reference Citation Analysis]
2 Kotsiou OS, Gourgoulianis KI, Zarogiannis SG. The role of nitric oxide in pleural disease. Respir Med 2021;179:106350. [PMID: 33662805 DOI: 10.1016/j.rmed.2021.106350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bandiera T, Galietta LJV. Pharmacological approaches to cystic fibrosis. Eur J Med Chem 2021;216:113240. [PMID: 33691259 DOI: 10.1016/j.ejmech.2021.113240] [Reference Citation Analysis]